Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

BREM vs. MEDEX: which is better?

Bottom line

BREM vs MEDEX: the short answer

BREM (iShares Emerging Markets Bond Active ETF) and MEDEX (MFS Emerging Markets Debt Fund) are both etfs.

Updated Nov 19, 2026

BREM vs MEDEX side by side

BREMMEDEX
TypeETFMutual fund
Fund familyiSharesMFS
CategoryEmerging-Markets BondEmerging-Markets Bond
Expense ratio—1.32%
Annual cost per $10k—$132
10-yr cost on $10k (prospectus)—$1,601
Max front loadNone0%
12b-1 fee—0.5%
1-yr return—+6.6%
5-yr return (annualized)—+0.7%
10-yr return (annualized)—+2.7%
Best quarter——
Worst quarter——
Net assets (fund)—$7.5B
Number of holdings—504
Portfolio turnover—69%
Returns as of—Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

BREM and MEDEX share none of their top holdings.

BREM top 10

    MEDEX top 10

    1. MFS Institutional Money Market Portfolio — 4.42%
    2. Argentina Republic Government International Bonds — 1.35%
    3. Argentina Republic Government International Bonds — 1.08%
    4. Ecuador Government International Bonds — 0.96%
    5. Argentina Republic Government International Bonds — 0.95%
    6. Dominican Republic — 0.89%
    7. Colombia Government International Bonds — 0.82%
    8. Dominican Republic — 0.73%
    9. Paraguay Government International Bonds — 0.70%
    10. Ecuador Government International Bonds — 0.69%

    FAQ

    What is the difference between BREM and MEDEX?
    BREM (iShares Emerging Markets Bond Active ETF) and MEDEX (MFS Emerging Markets Debt Fund) are both etfs.
    Should I own both BREM and MEDEX?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.